Oxygen-Amplified Carrier-Free Nanomedicine Integrating Ferroptosis/Photodynamic Therapy and COX-2/PGE2 Blockade for Robust Antitumor Immunity Against Glioma
ACS Applied Materials & Interfaces · 2026
DOI: 10.1021/acsami.6c14380 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Yinxing Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou350025, China. Hauptthemen laut MEDLINE: Glioma, Photochemotherapy, Ferroptosis. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province, Joint Funds for the Innovation of Science and Technology of Fujian Province, Science and Technology Innovation Platform Project of Fujian Science and Technology Plan.
Abstract (Originalsprache)
The therapeutic efficacy of glioma immunotherapy is severely hampered by immunosuppression in the tumor microenvironment. Here, we develop an oxygen‑amplified carrier‑free nanomedicine (IHC NPs) through hydrophobic self‑assembly of IR-820, hemin, and celecoxib. IHC NPs exhibit excellent stability, biological safety, and preferential tumor accumulation. In the subcutaneous glioma model, the combination of IHC NPs and αPD-L1 significantly inhibited subcutaneous tumor growth and effectively prevented distant tumor metastasis. Mechanistically, hemin catalyzes endogenous H2O2 to generate oxygen, thereby alleviating tumor hypoxia. This oxygen boost potentiates IR-820‑mediated photodynamic therapy and hemin-based ferroptosis, enhancing direct tumor cell killing. Concurrently, celecoxib blocks the COX‑2/PGE2 pathway, reversing immunosuppression within the tumor microenvironment. Through the synergistic strategy combining oxygen-sensitized photodynamic therapy, ferroptosis, COX-2/PGE2 suppression, and PD-1/PD-L1 blockade, this therapeutic regimen effectively induces tumor immunogenic cell death, promotes dendritic cell maturation, enhances intratumoral infiltration of cytotoxic T lymphocytes, reduces the abundance of regulatory T cells, and triggers the generation of effector memory T cells, thereby potently activating the host immune system. Collectively, our work provides a promising oxygen‑amplified carrier‑free nanomedicine for robust glioma immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou350025, China.
- Fujian Provincial Clinical Medical Research Center for Minimally Invasive Diagnosis and Treatment of Neurovascular Diseases of Fujian Medical University, Fuzhou350025, China.
- Department of Neurosurgery, Fuzong Teaching Hospital of Fujian University of Traditional Chinese Medicine (900th Hospital), Fuzhou350025, China.
- School of Biomedical Science, Huaqiao University, Quanzhou362021, China.
- Fujian Provincial Key Laboratory of Transplant Biology, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou350025, China.
ORCID-Profile: Xianquan Feng
Förderung
- Natural Science Foundation of Fujian Province
- Joint Funds for the Innovation of Science and Technology of Fujian Province
- Science and Technology Innovation Platform Project of Fujian Science and Technology Plan
Zitieren
APA
Huang, Y., Liu, B., Pan, Z., Huang, K., Wu, L., & Feng, X. (2026). Oxygen-Amplified Carrier-Free Nanomedicine Integrating Ferroptosis/Photodynamic Therapy and COX-2/PGE2 Blockade for Robust Antitumor Immunity Against Glioma. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c14380
Vancouver
Huang Y, Liu B, Pan Z, Huang K, Wu L, Feng X. Oxygen-Amplified Carrier-Free Nanomedicine Integrating Ferroptosis/Photodynamic Therapy and COX-2/PGE2 Blockade for Robust Antitumor Immunity Against Glioma. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c14380
BibTeX
@article{Huang2026,
author = {Huang, Yinxing and Liu, Bin and Pan, Zhenhong and Huang, Kaikai and Wu, Lina and Feng, Xianquan},
title = {Oxygen-Amplified Carrier-Free Nanomedicine Integrating Ferroptosis/Photodynamic Therapy and COX-2/PGE2 Blockade for Robust Antitumor Immunity Against Glioma},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.6c14380}
}
EUVIMED